Total Payments
$8,586
2024 Payments
$1,780
Companies
48
Transactions
482
Medicare Patients
1,185
Medicare Billing
$77,360
Payment Breakdown by Category
Food & Beverage$8,586 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,586 | 482 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,100 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,095 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $693.39 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $517.12 | 27 | $0 (2024) |
| Novo Nordisk Inc | $489.66 | 38 | $0 (2024) |
| Lilly USA, LLC | $454.42 | 27 | $0 (2024) |
| PFIZER INC. | $332.61 | 22 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $268.56 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $252.01 | 14 | $0 (2024) |
| Amgen Inc. | $230.48 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,780 | 92 | GlaxoSmithKline, LLC. ($373.39) |
| 2023 | $2,174 | 116 | ABBVIE INC. ($788.23) |
| 2022 | $2,108 | 111 | ABBVIE INC. ($516.98) |
| 2021 | $2,524 | 163 | AbbVie Inc. ($500.05) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Biological | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: PAIN | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Biological | ||||||
| 10/27/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: PAIN | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Obesity | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 207 | 274 | $34,730 | $15,166 |
| 2022 | 4 | 193 | 253 | $32,970 | $13,763 |
| 2021 | 10 | 389 | 502 | $60,961 | $27,409 |
| 2020 | 8 | 396 | 519 | $62,854 | $21,022 |
Total Patients
1,185
Total Services
1,548
Medicare Billing
$77,360
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 174 | $24,225 | $8,766 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $6,400 | $4,599 | 71.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 17 | $3,350 | $1,515 | 45.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 28 | $560.00 | $235.20 | 42.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 15 | $195.00 | $51.15 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 158 | $21,330 | $7,345 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $6,080 | $4,492 | 73.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 26 | $4,940 | $1,834 | 37.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 31 | $620.00 | $91.80 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 197 | 293 | $39,555 | $16,305 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $6,560 | $4,849 | 73.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 46 | $8,740 | $3,747 | 42.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $840.00 | $777.54 | 92.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 20 | $2,400 | $647.20 | 27.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 15 | 15 | $1,050 | $485.40 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $480.00 | $247.86 | 51.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 15 | 15 | $540.00 | $215.80 | 40.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 32 | $640.00 | $96.00 | 15.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 12 | $156.00 | $38.73 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 221 | 339 | $45,765 | $14,308 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 39 | 39 | $6,810 | $4,034 | 59.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 46 | 46 | $5,520 | $1,199 | 21.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 15 | $2,850 | $679.88 | 23.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 25 | 26 | $850.00 | $422.00 | 49.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $420.00 | $248.58 | 59.2% |
About Bruce Roe, PAC
Bruce Roe, PAC is a Physician Assistant healthcare provider based in Rocklin, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356433262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bruce Roe, PAC has received a total of $8,586 in payments from pharmaceutical and medical device companies, with $1,780 received in 2024. These payments were reported across 482 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,586).
As a Medicare-enrolled provider, Roe has provided services to 1,185 Medicare beneficiaries, totaling 1,548 services with total Medicare billing of $77,360. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Rocklin, CA
- Active Since 09/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1356433262
Products in Payments
- UBRELVY (Drug) $752.74
- NURTEC ODT (Drug) $515.81
- QULIPTA (Drug) $508.37
- TRELEGY ELLIPTA (Drug) $473.88
- VRAYLAR (Drug) $396.37
- JARDIANCE (Drug) $380.36
- FARXIGA (Drug) $363.95
- AREXVY (Drug) $292.78
- Kerendia (Drug) $268.56
- SHINGRIX (Biological) $262.13
- Ozempic (Drug) $211.06
- TRINTELLIX (Drug) $206.49
- Rybelsus (Drug) $199.90
- BREZTRI (Drug) $198.40
- LINZESS (Drug) $194.95
- XIFAXAN (Drug) $169.85
- MOUNJARO (Drug) $168.53
- EVENITY (Biological) $161.93
- Veozah (Drug) $159.77
- EMGALITY (Drug) $130.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Rocklin
Julie Castner, Pa, PA
Physician Assistant — Payments: $6,263
Physician Assistant $6,263
Michelle Geerts
Physician Assistant — Payments: $6,179
Physician Assistant $6,179
Caitlin O'malley, Pa, PA
Physician Assistant — Payments: $4,267
Physician Assistant $4,267
Dylan Neal
Physician Assistant — Payments: $2,232
Physician Assistant $2,232
Meaghan Berglund, Pa, PA
Physician Assistant — Payments: $1,564
Physician Assistant $1,564
Aspen Fernando
Physician Assistant — Payments: $1,547
Physician Assistant $1,547